| [1] | 
													
														WEI Mingjing, CHEN Wenqi. 
														
															Update of TRPV3 in the occurrence and treatment of skin diseases
														[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 66-70.
													 | 
												
																																																																																
													| [2] | 
													
														YANG Xiaoli, DENG Danqi. 
														
															Research progress of atopic dermatitis and metabolic syndrome
														[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 614-618.
													 | 
												
																																																																																
													| [3] | 
													
														YANG Zijing, PAN Meng, ZHAO Xiaoqing. 
														
															Dupilumab-induced immune drifting from atopic dermatitis to polymyalgia rheumatica: a case report
														[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 508-511.
													 | 
												
																																																																																
													| [4] | 
													
														HONG Anlan, LIN Tong. 
														
															Update of the role for TRP channels in inflammatory skin diseases
														[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 129-133.
													 | 
												
																																																																																
													| [5] | 
													
														WU Zhuoxuan, LI Meng, CHEN Jinbo, HU Feng, WANG Xiangdong, QIN Li. 
														
															Composition of gut microbiota between infants with atopic dermatitis and healthy infants
														[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 708-712.
													 | 
												
																																																																																
													| [6] | 
													
														HE Chun, LI Jingyi. 
														
															Atopic dermatitis-like monogenic diseases
														[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 764-769.
													 | 
												
																																																																																
													| [7] | 
													
														YAN Hongxia, HUA Ri, JIA Xiujuan, WANG Bailing, GAO Zhiqing, ZHANG Xiaofeng, WU Fenglan, MU Qiri. 
														
															Update of TRPV1 in the pathogenesis and treatment of atopic dermatitis
														[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 770-773.
													 | 
												
																																																																																
													| [8] | 
													
														LI Jibing, LI Wei, HU Cui, QIAN Yingying, ZHANG Ting, QIAN Hua. 
														
															Effects of climatic factors on the outpatient visits of children's atopic dermatitis in Suzhou
														[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(1): 11-14.
													 | 
												
																																																																																
													| [9] | 
													
														HUA Sirui, XU Kejia, WANG Lin. 
														
															Effect of ebastine on Balb/c mouse model of atopic dermatitis
														[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(6): 355-358.
													 | 
												
																																																																																
													| [10] | 
													
														CHEN Jing, ZHANG Shoumin. 
														
															Update of the study of immunological characteristics and management progress in the study of alopecia areata combined with atopic dermatitis
														[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(5): 343-346.
													 | 
												
																																																																																
													| [11] | 
													
														LI Mengmeng, LI Jingyi, LIU Qingfeng, LIU Youqing, LI Wei. 
														
															Clinical efficacy and safety of dupilumab in the treatment of moderate and severe atopic dermatitis for 16 weeks
														[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(12): 849-852.
													 | 
												
																																																																																
													| [12] | 
													
														JIANG Fei, ZHAO Qing, SUN Yonghu, ZHANG Zhaoxia, YANG Baoqi, YANG Qing, LIU Guoyan, SHI Zhongxiang, LIU Hong, ZHANG Furen. 
														
															Efficacy of dupilumab in 5 children with moderate-to-severe atopic dermatitis: a real-world study
														[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 790-793.
													 | 
												
																																																																																
													| [13] | 
													
														WU Zhe, YAO Zhirong. 
														
															Update of skin microbiome of common skin diseases in infant
														[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(3): 185-188.
													 | 
												
																																																																																
													| [14] | 
													
														HAN Yue, YAO Xu. 
														
															Activation and inflammation of HaCaT Cells regulated by exosomes in peripheral blood of the patients with atopic dermatitis
														[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(2): 70-74.
													 | 
												
																																																																																
													| [15] | 
													
														YANG Yan, CHEN Quan, LIU Yumei, ZHOU Xin, TIAN Xin, GAO Aili, XIONG Siying, CHEN Xiaoyin, LI Wei, ZHU Huilan. 
														
															Correlation between single nucleotide polymorphisms of IL-33/IL1RL1 genes and atopic dermatitis
														[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(11): 649-652.
													 |